Prophylix Pharma As

Tto Nord As

Jens Kjeldsen-Kragh

Bjorn Ragnar Skogen

Anne Husebekk

Mette Kjaer

Anne Husse-Bekk

Mette Kjaer Killie

Bjørn Skogen

Mette Kjær Killie

A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA 1a within 72 hours after delivery in the first non-compatible pregnancy.

Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT)

A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA1a within 72 hours after delivery in the first non-compatible pregnancy.

Growing community of inventors

Eiksmarka, Norway

Jens Kjeldsen-Kragh